We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current T2DH34 market cap is 294.41M. The company's latest EPS is USD -5.8155 and P/E is -1.52.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 660.53M | 646.13M | 642.44M | 640.51M | 640.49M |
| Operating Income | -35.08M | -87.12M | -841.15M | -44.4M | -48.22M |
| Net Income | -28.89M | -81.89M | -837.67M | -33.28M | -48.41M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.09B | 2.03B | 2.41B | 2.6B | 2.57B |
| Operating Income | -506.42M | -265.63M | -13.65B | -248.55M | -1.02B |
| Net Income | -485.14M | -428.79M | -13.66B | -220.37M | -1B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.39B | 4.32B | 3.52B | 3.53B | 3.52B |
| Total Liabilities | 2.07B | 2.03B | 2.02B | 2.02B | 2.03B |
| Total Equity | 2.33B | 2.29B | 1.5B | 1.51B | 1.49B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 17.76B | 17.73B | 4.35B | 4.39B | 3.52B |
| Total Liabilities | 1.87B | 1.69B | 2.04B | 2.07B | 2.03B |
| Total Equity | 15.88B | 16.05B | 2.31B | 2.33B | 1.49B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 350.02M | 8.92M | 97.6M | 207.78M | 293.68M |
| Investing | -156.35M | -35.51M | -63.26M | -94.41M | -124.05M |
| Financing | 10.85M | 1.75M | 5.56M | 6.25M | 8.31M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -53.51M | 193.99M | 189.29M | 350.02M | 293.68M |
| Investing | -590.98M | -72.98M | -167.74M | -156.35M | -124.05M |
| Financing | 859.14M | 40.95M | 6.5M | 10.85M | 8.31M |
| Market Cap | 294.41M |
| Price to Earnings Ratio | -1.52 |
| Price to Sales Ratio | 0.59 |
| Price to Cash Ratio | 1.17 |
| Price to Book Ratio | 1.02 |
| Dividend Yield | - |
| Shares Outstanding | 172.17M |
| Average Volume (1 week) | 895 |
| Average Volume (1 Month) | 3.95k |
| 52 Week Change | -30.77% |
| 52 Week High | 3.14 |
| 52 Week Low | 1.24 |
| Spread (Intraday) | 0.63 (27.63%) |
| Company Name | Teladoc Health Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.teladochealth.com |
| Industry | offices of medical doctors (8011) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
